Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RICE, G-CSF, and Plerixafor for PBSC mobilization in CD20+ NHL
NCT01097057Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Nov 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in non-Hodgkin lymphoma (NHL), sponsored by Fred Hutchinson Cancer Center. Started Nov 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01097057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097057.